NASDAQ:AQST

Aquestive Therapeutics Earning Date

USA |NASDAQ |USD

AQST Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 2, 2021 Sep 2021 $-0.45 $-0.33 $-0.49
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 2, 2021 Sep 2021 $11.01M $15.35M $8.26M

Aquestive Therapeutics's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 2021.

AQST Earnings Date & History Chart

AQST Earnings & Revenue Forecast

AQST Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.50 $-0.63 $-0.29
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-1.70 $-1.93 $-1.29
Dec 2022 4 $-1.41 $-1.76 $-1.02

AQST Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.50 $-0.50 $-0.45
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.70 $-1.70 $-1.73
Dec 2022 0 / 1 $-1.36 $-1.36 $-1.28

AQST Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $10.87M $9.74M $13.50M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $48.32M $45.87M $54.33M
Dec 2022 5 $68.81M $62.70M $76.60M

AQST Earnings Date & Revenue History

AQST Earnings History

|
Show More
Show More

AQST Revenue History

|
Show More
Show More

Aquestive Therapeutics Next Earnings Date & Report

AQST Next Earnings Date & Report Preview: Sep 2021 (FQ)

AQST's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Aquestive Therapeutics's next quarterly earnings is $-0.45, with a low EPS estimation of $-0.54, and a high estimation of $-0.26.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.45, the last 2 month trend is $-0.45, and the 3 month trend is $-0.43.

Based on 5 analysts, the average revenue estimation is $11.01M, with a low revenue estimation of $9.67M, and a high estimation of $14.40M.

Aquestive Therapeutics Previous Earnings Dates & Reports

AQST Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Aquestive Therapeutics's previous earnings date was Aug 3, 2021 for its fiscal quarter ended Jun 30, 2021.

AQST's earnings per share (EPS) was $-0.33, beating the consensus analysts forecast of $-0.44 by 25.34%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -19.51%, and lower than the same period a year before (Jun 2020) by 371.43%.

Revenues were $15.35M, better than the forecast of $15.35M by 0.00%, up by 37.97% from the previous quarter , and down by -29.20% from the same period last year.

The company reported a net income of $-12.37M.

Free cash flow for the quarter was $-1.95M , compared to $-14.20M last quarter and $-10.11M a year before.

AQST ended the quarter with $42.46M in total debt, an increase of 2.36% compared to the previous quarter, and a decrease of -31.73% compared to the same quarter a year before.

AQST Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aquestive Therapeutics's previous annual earnings date was Mar 9, 2021 for its fiscal year ended Dec 31, 2020.

AQST's earnings per share (EPS) was $-1.66, missing the consensus analysts forecast of $-1.34 by 23.88% , and higher than the previous year's EPS (Dec 2019) by -31.69%.

Revenues were $45.85M, better than the forecast of $44.95M by 2.00%, and down by -12.85% from previous year's revenue.

The company reported a net income of $-55.78M.

Aquestive Therapeutics reported a free cash flow of $-45.98M for its fiscal year, compared to $-60.87M a year ago.

The company ended the fiscal year with $40.48M in total debt, a decrease of -32.91% compared to the previous year.